FIERCELY
FOCUSED
on the development of novel
treatments for patients with
B-cell malignancies and
autoimmune diseases.
Latest News
TG Therapeutics to Present at the Jefferies London Healthcare Conference
Presentation scheduled for Wednesday, November 20, 2019 11:20 AM GMT NEW YORK , Nov. 18, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss , the Company’s Executive Chairman and Chief Executive Officer, will present at the Jefferies London
Read More >
